secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001641172-25-009967
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma restates FY2024 financials; prior statements not reliable
-------------------------------------------------------------------------

- Non-reliance on unaudited FY2024 financials filed Nov 20, 2024; share compensation and derivative liability corrected.
- Derivative liability increased by $6,816; total liabilities restated to $5.38M.
- Net loss restated from $809,255 to $668,255, improvement of $198,995.
- Prepaid assets reduced by $16,527; total assets restated to $161,084.
- Additional paid-in capital decreased by $17,492; AOCI shows negative $204,847 from reclassification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000164117225009967/0001641172-25-009967-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000164117225009967/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-009967

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer